AIRLINK 62.02 Increased By ▲ 1.59 (2.63%)
BOP 5.33 Decreased By ▼ -0.02 (-0.37%)
CNERGY 4.53 Decreased By ▼ -0.07 (-1.52%)
DFML 15.57 Increased By ▲ 0.73 (4.92%)
DGKC 65.68 Increased By ▲ 0.88 (1.36%)
FCCL 17.50 Increased By ▲ 0.64 (3.8%)
FFBL 28.00 Increased By ▲ 3.25 (13.13%)
FFL 9.25 Increased By ▲ 0.19 (2.1%)
GGL 10.05 Increased By ▲ 0.09 (0.9%)
HBL 105.38 Increased By ▲ 1.17 (1.12%)
HUBC 122.70 Increased By ▲ 5.18 (4.41%)
HUMNL 6.60 Increased By ▲ 0.06 (0.92%)
KEL 4.48 Decreased By ▼ -0.07 (-1.54%)
KOSM 4.45 Decreased By ▼ -0.12 (-2.63%)
MLCF 35.85 Increased By ▲ 0.44 (1.24%)
OGDC 122.60 Increased By ▲ 0.21 (0.17%)
PAEL 23.12 Increased By ▲ 1.21 (5.52%)
PIAA 29.34 Increased By ▲ 2.05 (7.51%)
PIBTL 5.82 Decreased By ▼ -0.12 (-2.02%)
PPL 106.22 Decreased By ▼ -1.15 (-1.07%)
PRL 27.04 Increased By ▲ 0.53 (2%)
PTC 18.34 Increased By ▲ 2.24 (13.91%)
SEARL 52.90 Decreased By ▼ -0.73 (-1.36%)
SNGP 63.20 Increased By ▲ 2.00 (3.27%)
SSGC 10.80 Increased By ▲ 0.05 (0.47%)
TELE 9.41 Increased By ▲ 0.92 (10.84%)
TPLP 11.35 Increased By ▲ 0.77 (7.28%)
TRG 71.65 Increased By ▲ 1.74 (2.49%)
UNITY 23.65 Increased By ▲ 0.14 (0.6%)
WTL 1.29 Increased By ▲ 0.01 (0.78%)
BR100 6,938 Increased By 59.9 (0.87%)
BR30 22,796 Increased By 227.2 (1.01%)
KSE100 67,080 Increased By 532.5 (0.8%)
KSE30 22,070 Increased By 155 (0.71%)
Business & Finance

Pharma giant GSK to lay off 720 workers in Belgium

British pharmaceutical giant GSK plans to cut up to 720 mainly senior jobs from its vaccine division in Belgium and
Published February 5, 2020
  • British pharmaceutical giant GSK plans to cut up to 720 mainly senior jobs from its vaccine division in Belgium and not renew 215 temporary contracts, it said Wednesday.
  • One part of the new structure is to focus on research and development, particularly on the science of the human immune system, and another on public healthcare.
  • GSK Vaccines managing director Patrick Florent said that he understood the emotion that such a large round of lay off could cause the workforce.

BRUSSELS: British pharmaceutical giant GSK plans to cut up to 720 mainly senior jobs from its vaccine division in Belgium and not renew 215 temporary contracts, it said Wednesday.

The global company is the biggest private employer in Belgium's French-speaking region, with 9,000 staff in three production plants and its vaccine operations centre.

"A transformation plan was therefore presented to the works council today," GlaxoSmithKline (GSK) said, in a statement.

"Several departments ... will be affected by this transformation project, including R&D, manufacturing and quality control, as well as global support functions."

GSK Vaccines managing director Patrick Florent said that he understood the emotion that such a large round of lay off could cause the workforce.

But he said that discussion would begin immediately with staff representatives on the impact of the plan, and vowed GSK would retain a "strategic" commitment to Belgium.

GlaxoSmithKline's global headquarters reported lower than expected earnings on Wednesday, along with a two-year plan to split the company in two.

One part of the new structure is to focus on research and development, particularly on the science of the human immune system, and another on public healthcare.

Comments

Comments are closed.